Skip to content
HelpLine 1-800-298-2436 support@go2.org
General Questions 650-598-2857 info@go2.org
  • About
  • Research
  • Blog
  • Advocacy
  • For Professionals
  • Donate
GO2 for Lung Cancer Logo
  • Home
  • What is Lung Cancer
    • Symptoms
    • Diagnosis
    • Coping with Diagnosis
    • Types of Lung Cancer
    • Lung Cancer Staging
    • Second Opinions
    • Lung Cancer Facts
  • Risk & Early Detection
    • About Screening
      • Frequently Asked Questions
      • Screening Facts & Figures
    • Risk Factors
    • Screening Centers
  • Treatments & Side Effects
    • Biomarker Testing
    • Clinical Trials
      • Frequently Asked Questions About Clinical Trials
    • Treatment Options
      • Chemotherapy
      • Radiation
      • Surgery
      • Immunotherapy
        • Checkpoint Inhibitors
        • Vaccines
        • Molecular Tests and Biomarkers
      • Targeted Therapy
        • Drugs Targeting EGFR
        • Drugs Targeting ALK
        • Drugs Targeting ROS1
        • Drugs Targeting BRAF
        • Drugs Targeting KRAS
        • Drugs Targeting NTRK
        • Drugs Targeting MET
        • Drugs Targeting RET
        • Other Targeted Therapies
      • Clinical Trials
      • Ablation Therapy
      • Complementary and Alternative Medicine
      • Hospice Care
      • Palliative Care
      • Photodynamic Therapy
    • Cancer Care Centers
    • Side Effect Management
    • Lung Cancer Stigma
    • Staying Healthy
  • Resources & Support
    • Our Services
      • HelpLine & Support
      • LungMATCH: Treatment Guidance
      • Phone Buddy
      • Financial and Other Resources
    • Support Group Network
    • Lung Cancer Living Room®
    • Gathering HOPE
    • Patient Communities
    • Educational Materials
      • Download or Order Educational Materials
      • The Living Room: A Lung Cancer Community of Courage
      • Questions for Your Healthcare Team
    • Video Library
  • Get Involved
    • Lung Cancer Awareness
    • Ways to Give
    • Events
    • Your Support Makes An Impact
    • Share Your Story
    • Join the Lung Cancer Registry
    • Volunteer as a Phone Buddy
    • Become an Ambassador
    • Start a Fundraiser
    • Honor a Loved One

ASCO-23-qol-blog

Bethany Johnson (GO2 for Lung Cancer)2023-07-25T14:46:00-05:00July 25th, 2023|0 Comments

Share

FacebookTwitterLinkedInTumblrPinterestEmail

Leave A Comment Cancel reply


The reCAPTCHA verification period has expired. Please reload the page.

Categories

  • Advocacy in Action
  • Community Engagement
  • Hot Topics
  • News
  • Newsletter Articles
    • Magnifying LeNS
    • Monthly Measure
    • Your Community
  • Press Releases
  • Science and Research
    • Small Cell Lung Cancer
  • Spotlights
    • Fundraisers
    • Small Cell Lung Cancer Spotlight
    • Survivors
    • Veterans
    • Women
  • Stories of Hope

Recent Posts

  • FDA Approves Ensacove (ensartinib) for Locally Advanced or Metastatic ALK-Positive NSCLC
  • The Women and Lung Cancer Research and Preventive Services Act Passes!
  • Raising Her Voice: Dusty’s Story
  • Ask the Experts: The Holidays and Cancer
  • Living Room Show Notes: Shared Decision-Making & Second Opinions

Archives

© 2022 GO2 for Lung Cancer. The information presented in this website is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you get from this website.
  • About Us
  • Research
  • Blog
  • Advocacy
  • For Professionals
  • HelpLine: 1-800-298-2436
  • General Questions: 202-463-2080 and 650-598-2857
Go to Top